Evidence map›Paper›PMID 27819674›Full record

ArticleOncogene2017

MMTV-cre;Ccn6 knockout mice develop tumors recapitulating human metaplastic breast carcinomas.

E E Martin, W Huang, T Anwar, C Arellano-Garcia, B Burman, J-L Guan, M E Gonzalez, C G Kleer

Open access · bronzeAbstract read
In one paragraph

Article in Oncogene, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Cancer-associated Fibroblasts induce epithelial-mesenchymal transitionInternational journal of biological sciences · 2020
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

E E MartinDepartment of Pathology and Comprehensive Cancer Center, University of Michigan, Ann Arbor, MI, USA.
W HuangDepartment of Pathology and Comprehensive Cancer Center, University of Michigan, Ann Arbor, MI, USA.
T AnwarDepartment of Pathology and Comprehensive Cancer Center, University of Michigan, Ann Arbor, MI, USA.
C Arellano-GarciaDepartment of Pathology and Comprehensive Cancer Center, University of Michigan, Ann Arbor, MI, USA.
B BurmanDepartment of Pathology and Comprehensive Cancer Center, University of Michigan, Ann Arbor, MI, USA.
J-L GuanDepartment of Cancer Biology, University of Cincinnati, Cincinnati, OH, USA.
M E GonzalezDepartment of Pathology and Comprehensive Cancer Center, University of Michigan, Ann Arbor, MI, USA.
C G KleerDepartment of Pathology and Comprehensive Cancer Center, University of Michigan, Ann Arbor, MI, USA.
University of Michigan–Ann Arbor · USMichigan Center for Translational Pathology · USUniversity of Cincinnati · US

Funding

XenograftP30CA046592 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI THEODORE S LAWRENCE · 1988 to 2026
$178.2M
University of Michigan Postbaccalaureate Research Education Program (UM PREP)R25GM086262 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ALLEN, BENJAMIN · 2009 to 2024
$6.1M
Role of EZH2 in Breast Cancer ProgressionR01CA107469 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Celina G Kleer · 2005 to 2026
$5.9M
Role of CCN6 (WISP3) in the Progression and Metastasis of Breast Cancer.R01CA125577 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Celina G Kleer · 2008 to 2026
$5.5M
Role of LIBC in Inflammatory Breast Cancer PhenotypeK08CA090876 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KLEER, CELINA G · 2003 to 2007
$679k
Non-canonical functions of EZH2 in triple-negative breast cancerF30CA196084 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ANWAR, TALHA · 2015 to 2017
$103k
NCI NIH HHS F30 CA196084NCI NIH HHS K08 CA090876NCI NIH HHS P30 CA046592NCI NIH HHS R01 CA107469NCI NIH HHS R01 CA125577NIGMS NIH HHS R25 GM086262
6 · The paper itself

Abstract

Metaplastic breast carcinoma is an aggressive form of invasive breast cancer with histological evidence of epithelial to mesenchymal transition (EMT). However, the defining molecular events are unknown. Here we show that CCN6 (WISP3), a secreted matricellular protein of the CCN (CYR61/CTGF/NOV) family, is significantly downregulated in clinical samples of human spindle cell metaplastic breast carcinoma. We generated a mouse model of mammary epithelial-specific Ccn6 deletion by developing a floxed Ccn6 mouse which was bred with an MMTV-Cre mouse. Ccn6

Indexed as

Disease Models, AnimalAnimalsBreastBreast NeoplasmsCCN Intercellular Signaling ProteinsFemaleGenes, Tumor SuppressorHumansMaleMammary Neoplasms, AnimalMetaplasiaMiceMice, Inbred StrainsMice, KnockoutCCN6 protein, mouseCCN Intercellular Signaling Proteins

Identifiers

PMID27819674
PMCPMC5398917
OpenAlexW2556823614

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.